Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
59°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about UCBJY
Recent news which mentions UCBJY
Longboard Pharmaceuticals Boasts High-Value Epilepsy Assets, Analyst Initiates Coverage
September 10, 2024
Tickers
LBPH
NEWS
UCBJF
UCBJY
Tags
News
Health Care
Initiation
From
Benzinga
Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB
August 29, 2024
Tickers
ARGX
JNJ
NEWS
UCBJF
Tags
Top Stories
Health Care
JNJ
From
Benzinga
Belgium-Based Pharma Firm UCB To Offload China Neurology, Allergy Business For $680M To Asset Management Companies
August 26, 2024
Tickers
NEWS
UCBJF
UCBJY
Tags
Briefs
Biotech
Stories That Matter
From
Benzinga
There's Optimism Around Longboard Pharmaceuticals' Anti-Seizure Candidate: Analyst Boosts Price Target
January 02, 2024
Tickers
LBPH
NEWS
UCBJF
UCBJY
Tags
Price Target
Expert Ideas
Briefs
From
Benzinga
Dianthus' Monoclonal Antibody On Promising Pathway To Gaining The Upper Hand - Analyst
September 28, 2023
Tickers
AZN
DNTH
SNY
UCBJF
Tags
DNTH
Trading Ideas
Health Care
From
Benzinga
Skin Disease Focused MoonLake Immunotherapeutics Poised To Outshine Rivals, Analyst Asserts
August 31, 2023
Tickers
MLTX
SLRN
UCBJF
UCBJY
Tags
Biotech
Benzinga
MLTX
From
Benzinga
FDA Approves Rystiggo: The Only Treatment for Two Most Common Subtypes of Generalized Myasthenia Gravis in Adults
June 27, 2023
Tickers
ARGX
UCBJF
UCBJY
Tags
News
Briefs
Biotech
From
Benzinga
Cantor On MoonLake Immunotherapeutics - Initiates On Inexpensive Valuation, Strong Catalyst Path
February 14, 2023
Tickers
MLTX
NVS
UCBJF
UCBJY
Tags
Analyst Color
UCBJF
NVS
From
Benzinga
The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More
May 30, 2022
Tickers
ABBV
ALPN
AUPH
BLCO
Tags
Penny Stocks
News
ALPN
From
Benzinga
‘The capitulation model for biotech is a Category 5 storm, the same as energy in 2020’ — why contrarians say the sector is a buy
May 20, 2022
Tickers
BMY
FATE
IBB
JNJ
Tags
CAMOX
PFE
XBI
From
MarketWatch
UCB's Rare Childhood Epilepsy Drug Scores FDA Approval
March 28, 2022
Tickers
UCBJF
UCBJY
Tags
Briefs
News
Biotech
From
Benzinga
Biogen-Xbrane Enter License Agreement For Cimzia Referenced Biosimilar, Xcimzane
February 08, 2022
Tickers
BIIB
UCBJF
UCBJY
Tags
UCBJF
UCBJY
Market News
From
Benzinga
The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More
January 23, 2022
Tickers
ABT
CUE
DCPH
ETON
Tags
DCPH
Biotech
ABT
From
Benzinga
UCB's Bispecific Marks Phase 3 Win For Second Psoriatic Arthritis Study
January 21, 2022
Tickers
UCBJF
UCBJY
Tags
UCBJY
UCBJF
Market News
From
Benzinga
ZGNX Stock: The $1.9B UCB Deal That Has Zogenix Shares Zooming Higher Today
January 19, 2022
Tickers
SOFI
SONY
UCBJY
ZGNX
Tags
Market News
SOFI
SONY
From
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2021
September 02, 2021
Tickers
ALKS
ASMB
BLDE
CATB
Tags
TCBI
HENKY
PRTG
From
Benzinga
UCB Gets EU Approval For Bimekizumab In Psoriasis
August 25, 2021
Tickers
NVS
UCBJF
UCBJY
Tags
News
Trading Ideas
Health Care
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2021
August 23, 2021
Tickers
ACVA
CADL
CHK
CLR
Tags
OAS
TRIL
CADL
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 23, 2021
July 23, 2021
Tickers
ADVM
AGESY
AGFY
AHH
Tags
THRY
AIZ
AHH
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 9, 2021
July 09, 2021
Tickers
ALGN
ARGO
ASLN
BMBL
Tags
Analyst Ratings
ASLN
BSBK
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.